Aerie Pharmaceuticals reported $312.59M in Loan Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Aerie Pharmaceuticals AERI:US USD 312.59M 458K
Alimera Sciences ALIM:US USD 22.49M 6.8M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.05B
Horizon Pharma HZNP:US USD 2.55B 1.85M
Insmed INSM:US USD 807.48M 366K
JAZZ PHA JAZZ:US USD 5.7B 294.18M
Novartis NOVN:VX USD 21.24B 2.55B
Pacira Pharmaceuticals PCRX:US USD 714M 7.88M
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Revance Therapeutics RVNC:US USD 378.89M 506K
Teva Pharmaceutical Industries TEVA:US USD 18.5B 1.87B
Valeant Pharmaceuticals VRX:CN USD 20.8B 860M
Zoetis ZTS:US USD 5.21B 11M